article thumbnail

Metformin helps manage weight gain side effect of SGAs

European Pharmaceutical Review

SGAs used to treat bipolar disorder are often effective at helping young patients’ mental health improve but can have significant side effects including elevated blood pressure and glucose, increased appetite, as well as weight gain.

article thumbnail

Merck’s $1.3B Imago Buyout Brings Blood Cancer Drug to Rival BMS, Incyte & GSK

MedCity News

Merck is acquiring Imago BioSciences, a clinical-stage biotech whose lead drug is in development for myelofibrosis and other blood cancers. The deal gives the pharmaceutical giant a small molecule that could provide an alternative to a class of drugs that introduce dangerous side effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preventative approach could reduce immunotherapy side effects

European Pharmaceutical Review

Immunotherapy drugs like teclistamab can result in potentially fatal side effects, including CRS and immune cell-associated neurotoxicity syndrome (ICANS). The post Preventative approach could reduce immunotherapy side effects appeared first on European Pharmaceutical Review.

article thumbnail

DTC Study: Marketers misaligned with online health seeker needs

World of DTC Marketing

It’s more about weighing the benefit against the potential side effects. Given the lack of new DRC studies, we decided to take some of the money we earned to let one of our team lead a quantitative online DTC study. TV spots are the number one way people learn about new pharma products.

article thumbnail

CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug

MedCity News

Rapport Therapeutics’ lead program could offer more targeted epilepsy treatment compared to currently available anti-seizure medications, which introduce many side effects. The IPO will support plans to develop the oral small molecule in focal epilepsy as well as chronic pain and bipolar disorder.

article thumbnail

What’s the most significant change in DTC?

World of DTC Marketing

Today patients and caregivers want to know more about the product’s side effects and cost, and they also want to hear from current patients. As interest in these products spikes, it’s evident that the drug companies are choosing to remain silent, which leads to more people getting false or harmful information online.

article thumbnail

How Artificial Intelligence Could Be the Ultimate Weapon Against Cancer

MedCity News

With the rise of AI technologies, we could see significant advancements in cancer treatment, making it more efficient and potentially leading to a cure. By analyzing vast amounts of data from medical records, laboratory tests and imaging scans, AI algorithms can provide a more precise diagnosis, which can lead to better treatment outcomes.